semaglutide and testosterone in women Progress Injectable semaglutide shows promise for
Description
Personalized GLP-1 compounds for providers and patients.
And, Changing patterns of contraceptive use show routine contraception utilization down by 3% in 2023, and at the same time, emergency contraception use and sterilization visits up 35% and 11%, respectively
2- Stem cell therapies and gene therapies are moving from science fiction toward real human testing
As consumers seeking to lose weight face Ozempic shortages, many are turning to a booming, less regulated market for compounded versions of the drug.
In certain cases, DEXA scans have shown evidence of osteomalacia and reduced bone density
